• Issue

    Inflammatory Bowel Diseases: Volume 18, Issue 5

    803-1002
    May 2012
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Original Clinical Articles

Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis†

Haruhiko Ogata MD, PhD,  Jun Kato MD, PhD,  Fumihito Hirai MD, PhD,  Nobuyuki Hida MD, PhD,  Toshiyuki Matsui MD, PhD,  Takayuki Matsumoto MD, PhD,  Katsuyoshi Koyanagi MS,  Toshifumi Hibi MD, PhD, 
  • Pages: 803-808
  • First Published: 01 September 2011

Editorials

Calcineurin inhibition in severe ulcerative colitis: Lost in translation?

Maria Laura Annunziata MD,  Stephen B. Hanauer MD, 
  • Pages: 809-811
  • First Published: 11 August 2011

Original Clinical Articles

Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: A multicenter study

M. Barreiro-de Acosta MD, PhD,  O. García-Bosch MD,  R. Souto MD,  M. Mañosa MD,  J. Miranda MD,  V. García-Sanchez MD, PhD,  J. Gordillo MD,  S. Chacon MD,  C. Loras MD, PhD,  D. Carpio MD,  N. Maroto MD,  L. Menchén MD, PhD,  M. Rojas-Feria MD, PhD,  M. Sierra MD,  A. Villoria MD,  I. Marin-Jimenez MD,  on behalf of Grupo joven GETECCU , 
  • Pages: 812-817
  • First Published: 08 August 2011

Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: Results from the CHARM trial†‡

David T. Rubin MD,  Parvez Mulani PhD,  Jingdong Chao PhD,  Paul F. Pollack MD,  Arielle G. Bensimon BA,  Andrew P. Yu PhD,  Subrata Ghosh MD, 
  • Pages: 818-825
  • First Published: 01 September 2011

Adalimumab in steroid-dependent Crohn's disease patients: Prognostic factors for clinical benefit

Ambrogio Orlando MD,  Sara Renna MD, PhD,  Filippo Mocciaro MD, PhD,  Maria Cappello MD,  Roberto Di Mitri MD,  Claudia Randazzo MD,  Mario Cottone Prof, 
  • Pages: 826-831
  • First Published: 11 August 2011

Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillance†

Robert Goldstone MD,  Steven Itzkowitz MD,  Noam Harpaz MD, PhD,  Thomas Ullman MD, 
  • Pages: 832-837
  • First Published: 07 July 2011

Lymphoma risk in children and young adults with inflammatory bowel disease: Analysis of a large single-center cohort

Lori A. Ashworth MSW, BA,  Amy Billett MD,  Paul Mitchell MS,  Federica Nuti MD,  Corey Siegel MD, MPH,  Athos Bousvaros MD, MPH, 
  • Pages: 838-843
  • First Published: 01 September 2011

Clostridium difficile infection in newly diagnosed pediatric patients with inflammatory bowel disease: Prevalence and risk factors

Aleksandra Banaszkiewicz MD, PhD,  Kinga Kowalska-Duplaga MD, PhD,  Tomasz Pytrus MD, PhD,  Hanna Pituch,  Andrzej Radzikowski, 
  • Pages: 844-848
  • First Published: 20 September 2011

Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn's disease†

Jeremy Adler MD, MSc,  Darashana R. Punglia MD,  Jonathan R. Dillman MD,  Alexandros D. Polydorides MD, PhD,  Maneesh Dave MBBS, MPH,  Mahmoud M. Al-Hawary MD,  Joel F. Platt MD,  Barbara J. McKenna MD,  Ellen M. Zimmermann MD, 
  • Pages: 849-856
  • First Published: 24 June 2011

Cesarean section and offspring's risk of inflammatory bowel disease: A national cohort study†

Peter Bager PhD,  Jacob Simonsen MSc,  Nete Munk Nielsen PhD,  Morten Frisch PhD, DSc, 
  • Pages: 857-862
  • First Published: 07 July 2011

Totally laparoscopic total proctocolectomy: A safe alternative to open surgery in inflammatory bowel disease

Jennifer Holder-Murray MD,  Marco Zoccali MD,  Roger D. Hurst MD,  Konstantin Umanskiy MD,  Michele Rubin RN,  Alessandro Fichera MD, 
  • Pages: 863-868
  • First Published: 14 July 2011

Narcotic use for inflammatory bowel disease and risk factors during hospitalization†

Millie D. Long MD, MPH,  Edward L. Barnes MD,  Hans H. Herfarth MD, PhD,  Douglas A. Drossman MD, 
  • Pages: 869-876
  • First Published: 07 July 2011

Original Basic Science Articles

Tribbles 2 (Trib2) is a novel regulator of toll-like receptor 5 signaling†

Shu-Chen Wei MD, PhD,  Ian M. Rosenberg PhD,  Zhifang Cao PhD,  Alan S. Huett PhD,  Ramnik J. Xavier MD, PhD,  Daniel K. Podolsky MD, 
  • Pages: 877-888
  • First Published: 23 January 2012

Genome-wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathway†

Elaine R. Nimmo PhD,  James G. Prendergast PhD,  Marian C. Aldhous PhD,  Nicholas A. Kennedy MBBS,  Paul Henderson MBChB,  Hazel E. Drummond BSc,  Bernard H. Ramsahoye PhD,  David C. Wilson MD,  Colin A. Semple PhD,  Jack Satsangi FRSE, 
  • Pages: 889-899
  • First Published: 21 October 2011

Crohn's disease-associated polymorphism within the PTPN2 gene affects muramyl-dipeptide-induced cytokine secretion and autophagy†

Michael Scharl MD,  Jessica Mwinyi MD, PhD,  Anne Fischbeck PhD,  Katharina Leucht,  Jyrki J. Eloranta PhD,  Joba Arikkat,  Theresa Pesch,  Silvia Kellermeier,  Alma Mair,  Gerd A. Kullak-Ublick MD,  Kaspar Truninger MD,  Faiza Noreen PhD,  Jaroslaw Regula MD,  Pawel Gaj PhD,  Valerie Pittet PhD,  Christoph Mueller MD,  Claudia Hofmann PhD,  Michael Fried MD,  Declan F. McCole PhD,  Gerhard Rogler MD, PhD, 
  • Pages: 900-912
  • First Published: 21 October 2011

Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease†

Anna Negroni PhD,  Manuela Costanzo PhD,  Roberta Vitali PhD,  Fabiana Superti PhD,  Lucia Bertuccini PhD,  Antonella Tinari MSc,  Fabio Minelli,  Giovanni Di Nardo MD,  Federica Nuti MD,  Maria Pierdomenico PhD,  Salvatore Cucchiara PhD, MD,  Laura Stronati PhD, 
  • Pages: 913-924
  • First Published: 12 October 2011

Comprehensive analysis of the bacterial content of stool from patients with chronic pouchitis, normal pouches, or familial adenomatous polyposis pouches

Gerald W. Tannock PhD,  Blair Lawley PhD,  Karen Munro,  Christophe Lay PhD,  Corinda Taylor,  Christopher Daynes MB, CHB,  Lori Baladjay BSc,  Robin Mcleod MD,  Mark Thompson-Fawcett MD, 
  • Pages: 925-934
  • First Published: 23 November 2011

Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease†

Michael J. Docktor MD,  Bruce J. Paster PhD,  Shelly Abramowicz DMD, MPH,  Jay Ingram BS,  Yaoyu E. Wang PhD,  Mick Correll BS,  Hongyu Jiang PhD,  Sean L. Cotton BS,  Alexis S. Kokaras BS,  Athos Bousvaros MD, MPH, 
  • Pages: 935-942
  • First Published: 10 October 2011

Strain-specific colitis susceptibility in IL10-deficient mice depends on complex gut microbiota–host interactions†

Gwen Büchler DVM, PhD,  Melissa L. Wos-Oxley PhD,  Anna Smoczek,  Nils-H. Zschemisch Dr.rer.nat.,  Detlef Neumann Dr.rer.nat.,  Dietmar H. Pieper Dr.rer.nat.,  Hans J. Hedrich DVM,  Andre Bleich DVM, PhD, 
  • Pages: 943-954
  • First Published: 11 January 2012

Toll-like receptor-7 ligand imiquimod induces type I interferon and antimicrobial peptides to ameliorate dextran sodium sulfate-induced acute colitis

Satheesh K. Sainathan PhD,  Kumar S. Bishnupuri PhD,  Konrad Aden MD,  Qizhi Luo MD,  Courtney W. Houchen MD,  Shrikant Anant PhD,  Brian K. Dieckgraefe MD, PhD, 
  • Pages: 955-967
  • First Published: 26 September 2011

Basic Science Reviews

Free Access

Role of the microbiota in inflammatory bowel diseases

Nabeetha A. Nagalingam PhD,  Susan V. Lynch PhD, 
  • Pages: 968-984
  • First Published: 20 September 2011

Clinical Reviews

Free Access

Antitumor necrosis factor treatment for pediatric inflammatory bowel disease†

Charlotte I. de Bie MD,  Johanna C. Escher MD, PhD,  Lissy de Ridder MD, PhD, 
  • Pages: 985-1002
  • First Published: 20 September 2011